Independent relationship between microalbuminuria and plasminogen activator inhibitor-1 activity (PAI-1) activity in clinically healthy 58-year-old men

被引:19
作者
Agewall, S [1 ]
Lindstedt, G
Fagerberg, B
机构
[1] Huddinge Univ Hosp, Karolinska Inst, Dept Cardiol, S-14186 Huddinge, Sweden
[2] Goteborg Univ, Sahlgrenska Univ Hosp, Dept Clin Chem & Transfus Med, Gothenburg, Sweden
[3] Goteborg Univ, Sahlgrenska Univ Hosp, Dept Med, Gothenburg, Sweden
关键词
antithrombin III; fibrinogen; microalbuminuria; plasminogen activator inhibitor activity; tissue plasminogen activator antigen; protein C; protein S; tissue plasminogen activator; thrombin/antithrombin factor; urinary albumin excretion; von Willebrand factor;
D O I
10.1016/S0021-9150(00)00706-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this cross-sectional study was to investigate the relationship between low-grade albuminuria (microalbuminuria) and factors of the coagulation- and fibrinolysis systems in 104 clinically healthy 58-year-old men recruited from the general population. Urinary albumin excretion was significantly associated with body mass index, systolic and diastolic blood pressure, plasminogen activator inhibitor (PAI)-1 activity, tissue plasminogen activator (tPA) antigen, tPA activity (negatively) and protein S (P < 0.05). There were no associations between urinary albumin excretion and antithrombin III, fibrinogen, protein C, thrombin/antithrombin factor or von Willebrand factor. In multiple regression analysis urinary albumin excretion was independently and significantly associated with PAI-1 activity and systolic blood pressure (P < 0.05). In conclusion we report that urinary albumin excretion was independently and significantly associated with PAI-1 activity in clinically healthy 58-year-old men. This relationship may contribute to the previously reported increased cardiovascular morbidity in subjects with microalbuminuria. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:197 / 202
页数:6
相关论文
共 30 条
  • [1] MICROALBUMINURIA IN TREATED HYPERTENSIVE MEN AT HIGH-RISK OF CORONARY-DISEASE
    AGEWALL, S
    PERSSON, B
    SAMUELSSON, O
    LJUNGMAN, S
    HERLITZ, H
    FAGERBERG, B
    [J]. JOURNAL OF HYPERTENSION, 1993, 11 (04) : 461 - 469
  • [2] THE EFFICACY OF MULTIPLE RISK FACTOR INTERVENTION IN TREATED HYPERTENSIVE MEN DURING LONG-TERM FOLLOW-UP
    AGEWALL, S
    WIKSTRAND, J
    SAMUELSSON, O
    PERSSON, B
    ANDERSSON, OK
    FAGERBERG, B
    [J]. JOURNAL OF INTERNAL MEDICINE, 1994, 236 (06) : 651 - 659
  • [3] Prothrombin fragment 1+2 is a risk factor for myocardial infarction in treated hypertensive men
    Agewall, S
    Wikstrand, J
    Fagerberg, B
    [J]. JOURNAL OF HYPERTENSION, 1998, 16 (04) : 537 - 541
  • [4] Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus
    Agewall, S
    Wikstrand, J
    Ljungman, S
    Fagerberg, B
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (02) : 164 - 169
  • [5] CAROTID-ARTERY WALL INTIMA-MEDIA THICKNESS IS ASSOCIATED WITH INSULIN-MEDIATED GLUCOSE DISPOSAL IN MEN AT HIGH AND LOW CORONARY RISK
    AGEWALL, S
    FAGERBERG, B
    ATTVALL, S
    WENDELHAG, I
    URBANAVICIUS, V
    WIKSTRAND, J
    [J]. STROKE, 1995, 26 (06) : 956 - 960
  • [6] MICROALBUMINURIA, INSULIN SENSITIVITY AND HEMOSTATIC FACTORS IN NONDIABETIC TREATED HYPERTENSIVE MEN
    AGEWALL, S
    FAGERBERG, B
    ATTVALL, S
    LJUNGMAN, S
    URBANAVICIUS, V
    TENGBORN, L
    WIKSTRAND, J
    [J]. JOURNAL OF INTERNAL MEDICINE, 1995, 237 (02) : 195 - 203
  • [7] AZNAR J, 1988, BRIT HEART J, V59, P535
  • [8] BECKMANSUURKULA M, 1991, HYPERTENSION, V17, P661
  • [9] BOKEMARK L, 2000, IN PRESS J INT MED
  • [10] Expression of plasminogen activator inhibitor-1 in human adipose tissue:: a role for TNF-α?
    Cigolini, M
    Tonoli, M
    Borgato, L
    Frigotto, L
    Manzato, F
    Zeminian, S
    Cardinale, C
    Camin, M
    Chiaramonte, E
    De Sandre, G
    Lunardi, C
    [J]. ATHEROSCLEROSIS, 1999, 143 (01) : 81 - 90